A possible placental factor for preeclampsia: sFlt-1

被引：21

作者：

Kita, Naoko ^{[1
]}

Mitsushita, Junji ^{[2
]}

机构：

[1] Shinshu Univ, Sch Med, Dept Obstet & Gynecol, Nagano 3908621, Japan

[2] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA

来源：

CURRENT MEDICINAL CHEMISTRY | 2008年 / 15卷 / 07期

关键词：

preeclampsia; sFlt-1; PlGF; VEGF; hypoxia;

D O I：

10.2174/092986708783885309

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Despite its clinical importance, the mechanism of preeclampsia is unclear; however, many believe placental pathology might be related to maternal systemic disease. If this is true, a factor which mediates information from the placenta to the maternal circulation can be hypothesized. Among a variety of such reported factors, soluble fms-like tyrosine kinase-1 (sFlt1) will be the focus of this review. The hypoxic placenta, which is commonly found in preeclampsia, produces sFlt1; furthermore, animal experiments suggest its overexpression leads to preeclampsia-like symptoms.

引用

页码：711 / 715

页数：5

共 89 条

[51] Soluble fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia [J].

Maynard, SE ;

Venkatesha, S ;

Thadhani, R ;

Karumanchi, SA .

PEDIATRIC RESEARCH, 2005, 57 (05) :1R-7R

[52] Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfimction, hypertension, and proteinuria in preeclampsia [J].

Maynard, SE ;

Min, JY ;

Merchan, J ;

Lim, KH ;

Li, JY ;

Mondal, S ;

Libermann, TA ;

Morgan, LP ;

Sellke, FW ;

Stillman, IE ;

Epstein, FH ;

Sukhatme, VP ;

Karumanchi, SA .

JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (05) :649-658

[53] Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop [J].

McKeeman, GC ;

Ardill, JES ;

Caldwell, CM ;

Hunter, AJ ;

McClure, N .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 191 (04) :1240-1246

[54] A STUDY OF PLACENTAL BED SPIRAL ARTERIES AND TROPHOBLAST INVASION IN NORMAL AND SEVERE PREECLAMPTIC PREGNANCIES [J].

MEEKINS, JW ;

PIJNENBORG, R ;

HANSSENS, M ;

MCFADYEN, IR ;

VANASSHE, A .

BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1994, 101 (08) :669-674

[55] The role of integrins in human embryo implantation [J].

Merviel, P ;

Challier, JC ;

Carbillon, L ;

Foidart, JM ;

Uzan, S .

FETAL DIAGNOSIS AND THERAPY, 2001, 16 (06) :364-371

[56] Cytotrophoblasts up-regulate soluble Fms-like tyrosine kinase-1 expression under reduced oxygen: An implication for the placental vascular development and the pathophysiology of preeclampsia [J].

Nagamatsu, T ;

Fujii, T ;

Kusumi, M ;

Zou, L ;

Yamashita, T ;

Osuga, Y ;

Momoeda, M ;

Kozuma, S ;

Taketani, Y .

ENDOCRINOLOGY, 2004, 145 (11) :4838-4845

[57]

NORTH RA, 1994, OBSTET GYNECOL, V83, P378

[58] Blockade of vascular endothelial growth factor suppresses experimental restenosis after intraluminal injury by inhibiting recruitment of monocyte lineage cells [J].

Ohtani, K ;

Egashira, K ;

Hiasa, K ;

Zhao, QW ;

Kitamoto, S ;

Ishibashi, M ;

Usui, M ;

Inoue, S ;

Yonemitsu, Y ;

Sueishi, K ;

Sata, M ;

Shibuya, M ;

Sunagawa, K .

CIRCULATION, 2004, 110 (16) :2444-2452

[59] Screening test for preeclampsia through assessment of uteroplacental blood flow and biochemical markers of oxidative stress and endothelial dysfunction [J].

Parra, M ;

Rodrigo, R ;

Barja, P ;

Bosco, C ;

Fernández, V ;

Muñoz, H ;

Soto-Chacón, E .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 193 (04) :1486-1491

[60] Animal models of preeclampsia [J].

Podjarny, E ;

Baylis, C ;

Losonczy, G .

SEMINARS IN PERINATOLOGY, 1999, 23 (01) :2-13

← 1 2 3 4 5 6 7 8 9 →